CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,975,156
- in 10 filings, $2.0M under 10b5-1 plans
Net −$1,975,156. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-28 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Shares withheld for taxes | −2,221 | $73.90 | $164K | 74,916 |
| 2026-02-26 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Grant or award | +11,116 | $77.15 | $858K | 77,137 |
| 2026-02-14 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Shares withheld for taxes | −1,717 | $77.36 | $133K | 66,021 |
| 2026-02-12 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Shares withheld for taxes | −1,608 | $76.70 | $123K | 67,738 |
| 2026-02-11 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Shares withheld for taxes | −4,269 | $76.25 | $326K | 69,346 |
| 2025-11-13 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Sale | −94 | $88.00 | $8K | 158,490 |
| 2025-11-12 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Sale | −14,642 | $89.07 | $1.3M | 158,584 |
| 2025-08-15 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Sale | −20,000 | $86.97 | $1.7M | 173,226 |
| 2025-02-12 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Grant or award | +14,362 | 64,041 | ||
| 2025-02-12 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Grant or award | +9,574 | 73,615 | ||
| 2024-07-01 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Sale 10b5-1 | −20,000 | $63.44 | $1.3M | 193,226 |
| 2024-06-03 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Sale 10b5-1 | −20,000 | $64.41 | $1.3M | 213,226 |
| 2024-05-01 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Sale 10b5-1 | −20,000 | $66.62 | $1.3M | 233,226 |
| 2024-04-01 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Sale 10b5-1 | −20,000 | $67.25 | $1.3M | 253,226 |
| 2024-03-11 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Sale 10b5-1 | −20,000 | $65.81 | $1.3M | 273,226 |
| 2024-02-29 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Shares withheld for taxes | −1,635 | $67.67 | $111K | 49,679 |
| 2024-02-14 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Grant or award | +13,421 | 42,368 | ||
| 2024-02-14 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Grant or award | +8,946 | 51,314 | ||
| 2023-10-02 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Sale 10b5-1 | −20,000 | $56.48 | $1.1M | 293,226 |
| 2023-09-01 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Sale 10b5-1 | −20,000 | $64.70 | $1.3M | 313,226 |
Page 1 of 2 · 28 trades